BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 19863227)

  • 1. Dose prescription and optimisation based on tumour hypoxia.
    Toma-Daşu I; Daşu A; Brahme A
    Acta Oncol; 2009; 48(8):1181-92. PubMed ID: 19863227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of hypoxia on the theoretical modelling of tumour control probability.
    Daşu A; Toma-Daşu I; Karlsson M
    Acta Oncol; 2005; 44(6):563-71. PubMed ID: 16165915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment planning optimisation based on imaging tumour proliferation and cell density.
    Daşu A
    Acta Oncol; 2008; 47(7):1221-8. PubMed ID: 18654904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell-based computer simulation of the oxygen-dependent tumour response to irradiation.
    Harting C; Peschke P; Borkenstein K; Karger CP
    Phys Med Biol; 2007 Aug; 52(16):4775-89. PubMed ID: 17671335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of tumor repopulation on radiotherapy planning.
    Wang JZ; Li XA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More optimal dose distributions for moving lung tumours: a planning study.
    Cho BC; Craig T
    Radiother Oncol; 2006 Apr; 79(1):122-30. PubMed ID: 16621075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity modulated radiation therapy for oropharyngeal cancer: the sensitivity of plan objectives and constraints to set-up uncertainty.
    Ploquin N; Song W; Lau H; Dunscombe P
    Phys Med Biol; 2005 Aug; 50(15):3515-33. PubMed ID: 16030380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Future issues in highly conformal radiotherapy for head and neck cancer.
    Feng M; Eisbruch A
    J Clin Oncol; 2007 Mar; 25(8):1009-13. PubMed ID: 17350951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensity-modulated radiotherapy for soft tissue sarcoma of the thigh.
    Hong L; Alektiar KM; Hunt M; Venkatraman E; Leibel SA
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):752-9. PubMed ID: 15183478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying tumour hypoxia by PET imaging--a theoretical analysis.
    Toma-Daşu I; Daşu A; Brahme A
    Adv Exp Med Biol; 2009; 645():267-72. PubMed ID: 19227481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does heterogeneity of pimonidazole labelling correspond to the heterogeneity of radiation-response of FaDu human squamous cell carcinoma?
    Yaromina A; Hölscher T; Eicheler W; Rosner A; Krause M; Hessel F; Petersen C; Thames HD; Baumann M; Zips D
    Radiother Oncol; 2005 Aug; 76(2):206-12. PubMed ID: 16024121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the 3D-conformal, helical tomotherapy and multileaf collimators-based intensity modulated radiotherapy modalities using radiobiological measures.
    Mavroidis P; Costa Ferreira B; Shi C; Lind BK; Papanikolaou N
    J BUON; 2008; 13(1):75-86. PubMed ID: 18404791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
    Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
    Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A concomitant tumour boost in bladder irradiation: patient suitability and the potential of intensity-modulated radiotherapy.
    Muren LP; Redpath AT; McLaren D; Rørvik J; Halvorsen OJ; Høstmark J; Bakke A; Thwaites D; Dahl O
    Radiother Oncol; 2006 Jul; 80(1):98-105. PubMed ID: 16876274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A motion phantom study on helical tomotherapy: the dosimetric impacts of delivery technique and motion.
    Kanagaki B; Read PW; Molloy JA; Larner JM; Sheng K
    Phys Med Biol; 2007 Jan; 52(1):243-55. PubMed ID: 17183139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intensity modulated radiotherapy for local-regional advanced nasopharyngeal carcinoma].
    Zhao C; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Lu TX; Cui NJ
    Ai Zheng; 2004 Nov; 23(11 Suppl):1532-7. PubMed ID: 15566674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On dose distribution comparison.
    Jiang SB; Sharp GC; Neicu T; Berbeco RI; Flampouri S; Bortfeld T
    Phys Med Biol; 2006 Feb; 51(4):759-76. PubMed ID: 16467577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.